Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Insulet Corporation’s stock clocked out at $304.49, down -3.62% from its previous closing price of $315.92. In other words, the price has decreased by -$3.62 from its previous closing price. On the day, 0.52 million shares were traded. PODD stock price reached its highest trading level at $315.99 during the session, while it also had its lowest trading level at $302.96.
Ratios:
To gain a deeper understanding of PODD’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 28.28 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 50.57. For the most recent quarter (mrq), Quick Ratio is recorded 2.14 and its Current Ratio is at 2.83. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.68.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 26 ’25 when Manea Dan bought 4,475 shares for $326.64 per share.
Manea Dan bought 2,306 shares of PODD for $786,228 on Nov 24 ’25. On Sep 16 ’25, another insider, Manea Dan, who serves as the Former Officer of the company, bought 1,347 shares for $337.73 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PODD now has a Market Capitalization of 21433823232 and an Enterprise Value of 21738127360. As of this moment, Insulet’s Price-to-Earnings (P/E) ratio for their current fiscal year is 88.35, and their Forward P/E ratio for the next fiscal year is 48.87. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.55. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.49 while its Price-to-Book (P/B) ratio in mrq is 15.48. Its current Enterprise Value per Revenue stands at 8.62 whereas that against EBITDA is 42.549.
Stock Price History:
The Beta on a monthly basis for PODD is 1.39, which has changed by 0.14849877 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, PODD has reached a high of $354.88, while it has fallen to a 52-week low of $230.05. The 50-Day Moving Average of the stock is -4.89%, while the 200-Day Moving Average is calculated to be 1.28%.
Shares Statistics:
It appears that PODD traded 650.93K shares on average per day over the past three months and 816220 shares per day over the past ten days. A total of 70.35M shares are outstanding, with a floating share count of 70.05M. Insiders hold about 0.44% of the company’s shares, while institutions hold 100.24% stake in the company. Shares short for PODD as of 1763078400 were 1738367 with a Short Ratio of 2.67, compared to 1760486400 on 1610709. Therefore, it implies a Short% of Shares Outstanding of 1738367 and a Short% of Float of 3.7600000000000002.
Earnings Estimates
Current recommendations for the stock of the company come from 20.0 analysts. The consensus estimate for the next quarter is $1.19, with high estimates of $1.38 and low estimates of $0.94.
Analysts are recommending an EPS of between $5.26 and $4.75 for the fiscal current year, implying an average EPS of $4.89. EPS for the following year is $6.17, with 24.0 analysts recommending between $6.63 and $5.2.
Revenue Estimates
In. The current quarter, 21 analysts expect revenue to total $768.3M. It ranges from a high estimate of $778M to a low estimate of $755.6M. As of. The current estimate, Insulet Corporation’s year-ago sales were $597.5MFor the next quarter, 21 analysts are estimating revenue of $714.43M. There is a high estimate of $751.57M for the next quarter, whereas the lowest estimate is $681.5M.
A total of 24 analysts have provided revenue estimates for PODD’s current fiscal year. The highest revenue estimate was $2.7B, while the lowest revenue estimate was $2.67B, resulting in an average revenue estimate of $2.69B. In the same quarter a year ago, actual revenue was $2.07BBased on 24 analysts’ estimates, the company’s revenue will be $3.24B in the next fiscal year. The high estimate is $3.33B and the low estimate is $3.13B.
